IMUX

LIVE

Serial Number

79418815

Owner

Immunic AG

Attorney

James N Palik

Filing Date

Jan 23, 2025

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

IMUX Trademark

Serial Number: 79418815 • Registration: 8155697

IMUX is a trademark filed by Immunic AG on January 23, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Immunic AG (3 trademarks)

Lochhamer Schlag 21

Entity Type: 98

Legal Representation

Attorney of Record

James N Palik

423 trademarks filed View all →

Correspondence Address

James N Palik Attorney of record, New York State Bar m

3 Woodward Boulevard, Unit 216

Tulsa, OK 74114

United States

Trademark Details

Filing Date

January 23, 2025

Registration Date

March 3, 2026

Published for Opposition

January 13, 2026

Goods & Services

Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases

Pharmaceutical research and development

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 3, 2026 FICR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 3, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Mar 3, 2026 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 13, 2026 NPUB

PUBLISHED FOR OPPOSITION

Jan 13, 2026 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 7, 2026 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 15, 2025 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 14, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 14, 2025 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 14, 2025 TROA

REFUSAL PROCESSED BY IB

Sep 5, 2025 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Aug 19, 2025 RFCS

REFUSAL PROCESSED BY MPU

Aug 19, 2025 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jul 16, 2025 RFCR

NON-FINAL ACTION WRITTEN

Jul 15, 2025 CNRT

ASSIGNED TO EXAMINER

Jul 2, 2025 DOCK

APPLICATION FILING RECEIPT MAILED

Mar 14, 2025 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 14, 2025 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Mar 13, 2025 REPR

Related Trademarks

More from this Owner

VIDO

IMMUNIC THERAPEUTICS

More in Same Class

VTOX